Below is an extract taken from Acadia’s business and pipeline...

First 70 Last

Share
Profile

Follow
Taurean7

1,795 Posts.

3222

15/01/25

23:53

Post #: 77423043
Share

Originally posted by Mindspin ↑

From the announcement:

“Acadia also anticipates initiating Managed Access Programs in Europe in the second quarter of 2025.”

This prompts the question: will the MAPs be free of charge, or revenue-generating?

A whitepaper from PwC which I came across indicates that while charging for early access is possible in some markets, it may set a benchmark for future reimbursement negotiations in other territories and therefore the long-term pricing strategy should be a consideration.

My interpretation is that there may be some risk in charging a concessional price for the MAPs and therefore it is possible that a free of charge approach may be selected. If so, then what benefits would Acadia derive from it?

Current thoughts are as follows:

* Goodwill within the communities across the selected EU markets - which will be valuable to Acadia (as it is presently US-centric)
* Experience operating within the selected EU markets
* The ability to fine-tune their approach and communications within those markets (eg in relation to managing gastrointestinal issues) ahead of the approval so that optimal outcomes can be achieved

While a free MAP would result in Acadia experiencing additional net cash outflows in the short-term, it would indicate confidence that this will be beneficial in the longer term in view of some of the factors listed above.

From a Neuren perspective, this would not entail any cost (other than perhaps forgoing a small amount of royalties on the MAP) but would give exposure to the long term upside (particularly given the importance of hitting sales milestones).

Expand

Below is an extract taken from Acadia’s business and pipeline update yesterday. It seems obvious that Acadia expects to receive DAYBUE sales revenue from the Managed Access Programs initiated in Europe, possibly as early as Q2 2025.

Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference - Acadia Pharmaceuticals Inc.

NEU Price at posting: $11.01 Sentiment: Buy Disclosure: Held
35 Upvote

3 Great analysis

Reply

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

First 70 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $13.31		Change 0.770(6.14%)		Mkt cap ! $1.655B

Open	High	Low	Value	Volume
$12.96	$14.00	$12.91	$19.76M	1.453M

Buyers (Bids)

No.	Vol.	Price($)
1	3000	$13.30

Sellers (Offers)

Price($)	Vol.	No.
$13.33	3716	1

View Market Depth

No.	Vol.	Price($)
1	3000	13.300
2	10200	13.200
1	2500	13.190
2	1750	13.180
1	50	13.170

Price($)	Vol.	No.
13.330	3716	1
13.370	3716	1
13.390	600	1
13.400	3783	2
13.430	3716	1

Last trade - 16.10pm 26/06/2025 (20 minute delay)

NEU (ASX) Chart

Below is an extract taken from Acadia’s business and pipeline...

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Below is an extract taken from Acadia’s business and pipeline...

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News